ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • Subscription
  • Newsletter
  • Advertising
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Artificial Intelligence

Recap AI Circular Economy Conference 2026

The AI Circular Economy Conference 2026, organised by nova-Institute, brought together 116 participants from 15 countries in Cologne and online to explore the transformation of the chemical and materials industry supported and accelerated by artificial intelligence. more ➔

LATEST NEWS

Genentech headquarters in Silicon Valleyadobe stock photos - Sundry Photography

Swiss Roche builds its own AI factory with NVIDIA...

Chesterford Research Park

Mestag Therapeutics raises $40M and adds two senior...

Financing for validation of a new shuttle mechanism to release payload intracellular: iDEL therapeutics got a 9Mio shotadobe stock photos - deemerwha

Delivering drugs into cells: Seed funding for Germa...

ADVERTISEMENT

MAGAZINE

1 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

2 / 4
EB325_cover

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

3 / 4
01_EB225_Titel.indd

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

4 / 4
EB125_Cover

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

SPONSORED PUBLICATION

1 / 2
TW26_Infografik_Advertorial_115x65mm--2
Life Sciences Innovations Made in Europe

Research and Innovation as a Competitive Advantage – Legal framework for Life Sciences made in Europe

Research and innovation are considered key resources for European competitiveness – and essential location factors for research-intensive industries such as the Life Sciences. The European Union … more ➔

2 / 2
BioDlink heaquarters SuzhouBioDlink
Drug development

Solutions-Based Thinking: BioDlink’s Model for Successful CDMO Partnerships

In an interview with European Biotechnology Magazine during J.P. Morgan Week in San Francisco, Dr. Jian Zhang, Acting CEO of BioDlink, explains how a partnership-first approach and deep ADC expertise … more ➔

newsletter_link
Knowbio GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top